Christine Rouzioux

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption.

Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption.

Journal: Nature communications

Published: June 19, 2025

Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.

Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.

Journal: PLoS computational biology

Published: April 19, 2024

A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI/PRIMO.

A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI/PRIMO.

Journal: Med (New York, N.Y.)

Published: August 09, 2023

From the origin of Sars-CoV-2 to dangerous virology/biology

From the origin of Sars-CoV-2 to dangerous virology/biology

Journal: Bulletin de l'Academie nationale de medecine

Published: May 16, 2023

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Journal: Nature communications

Published: April 04, 2023

In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.

In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.

Journal: Microbiology spectrum

Published: January 24, 2023

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.

Journal: The Journal of antimicrobial chemotherapy

Published: April 22, 2022

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.

Journal: The Journal of antimicrobial chemotherapy

Published: March 20, 2022

SARS-CoV-2 variants in relation to screening and vaccines

SARS-CoV-2 variants in relation to screening and vaccines

Journal: Bulletin de l'Academie nationale de medecine

Published: December 21, 2021

Elite and viremic HIV-1 controllers in West Africa.

Elite and viremic HIV-1 controllers in West Africa.

Journal: AIDS (London, England)

Published: September 15, 2021

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.

Journal: EBioMedicine

Published: September 02, 2021

HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection.

HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection.

Journal: The Journal of antimicrobial chemotherapy

Published: July 16, 2021

Showing 1-12 of 133

Last Updated: 09/26/2026